Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Express Scripts
Cantor Fitzgerald
Cipla
McKesson
Colorcon
Farmers Insurance
Dow

Generated: April 24, 2018

DrugPatentWatch Database Preview

Grepafloxacin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for grepafloxacin hydrochloride and what is the scope of grepafloxacin hydrochloride freedom to operate?

Grepafloxacin hydrochloride
is the generic ingredient in one branded drug marketed by Otsuka and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for grepafloxacin hydrochloride
Synonyms for grepafloxacin hydrochloride
1-Cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid hydrochloride
161967-81-3
173689-78-6
967G813
AC-16082
AC1LCVLB
AK-60560
AKOS015962215
API0005596
CAS-161967-81-3
CHEMBL1200393
D02178
DSSTox_CID_26692
DSSTox_GSID_46692
DSSTox_RID_81826
DTXSID0046692
GPFX
Grepafloxacin HCl
Grepafloxacin hydrochloride (JAN/USAN)
Lungaskin
NCGC00167527-01
NCGC00167527-03
OPC-17116
Raxar (TN)
SCHEMBL137804
Tox21_112524
Tox21_112524_1
Vaxar

US Patents and Regulatory Information for grepafloxacin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka RAXAR grepafloxacin hydrochloride TABLET;ORAL 020695-001 Nov 6, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Otsuka RAXAR grepafloxacin hydrochloride TABLET;ORAL 020695-003 May 14, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Otsuka RAXAR grepafloxacin hydrochloride TABLET;ORAL 020695-002 May 14, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Teva
Healthtrust
US Department of Justice
Harvard Business School
Covington
Baxter
Chinese Patent Office
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.